
Alex Zhavoronkov follows landmark AI paper with $37M round for Insilico featuring top-notch China VCs

Days after Alex Zhavoronkov’s team demonstrated just how their generative machine learning model could be used to discover new compounds, Chinese investors are once again congregating at Insilico’s corner to offer a fresh round of cash to move that work forward.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 102,400+ biopharma pros reading Endpoints daily — and it's free.